Technology-based and supervised exercise interventions for individuals with type 2 diabetes: Randomized controlled trial

被引:12
|
作者
Timurtas, Eren [1 ]
Inceer, Mehmet [2 ,3 ]
Mayo, Nancy [2 ,3 ]
Karabacak, Neslihan [1 ]
Sertbas, Yasar [4 ]
Polat, Mine Gulden [1 ]
机构
[1] Marmara Univ, Dept Phys Therapy & Rehabil, Fac Hlth Sci, TR-34854 Istanbul, Turkey
[2] McGill Univ, Fac Med & Hlth Sci, Sch Phys & Occupat Therapy, Montreal, PQ, Canada
[3] McGill Univ, Hlth Ctr, Res Inst, Ctr Outcomes Res & Evaluat CORE, Montreal, PQ, Canada
[4] Fatih Sultan Mehmet Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey
关键词
Type; 2; diabetes; Exercise; Glycemic control; Rehabilitation; Mobile health; Wearable smartwatch; Technology; HbA1c; MOBILE PHONE APPLICATIONS; PHYSICAL-ACTIVITY; SELF-MANAGEMENT; GLYCEMIC CONTROL; METAANALYSIS; HEALTH; QUESTIONNAIRE; RELIABILITY; STATEMENT;
D O I
10.1016/j.pcd.2021.12.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The purpose of this study was to estimate, for people with type 2 diabetes (T2D), the extent to which glycemic control was affected by a 12-week program using mobile app and wearable smartwatch in comparison to supervised exercise training. Methods: This study was a stratified, randomized, assessor-blind, controlled, pragmatic trial with three parallel groups which were supervised, mobile app and wearable smartwatch. Individually tailored exercise regimens delivered through a supervisor, mobile app and wearable smartwatch. Programs consisted of aerobic, resistance exercises, calisthenic, flexibility, balance, and coordination exercises. Primary outcome was change in glycemic control (HbA1c); secondary outcome was Six Minute Walk Test; and explanatory outcomes were exercise behaviour, muscle function, and physical capacity. The groups were contrasted for change in HbA1c and absolute reduction of >= 0.5% (Minimal Important Change). Linear and logistic regressions were used to compare the groups and generalized estimated equations were used to analyze the explanatory outcomes. Results: In total, 90 people were randomized, 6 were lost over 12 weeks, leaving 84 with outcome data. The difference in HbA1c did not differ between the supervised and the technology groups combined and between the mobile app and smartwatch group. Proportions of people achieving a clinically meaningful difference on HbA1c between the supervised and technology groups were similar (46% vs 43%) and the associated OR was 0.87 (95%CI:0.34-2.28). Within the two technology groups, proportions of people achieving a clinically meaningful difference in HbA1c were 48% in the mobile app and 38% in the smartwatch groups and the associated OR was 0.65 (95%CI:0.21-2.03). The groups did not differ on secondary and explanatory outcomes. Conclusions: The results of our trial provide evidence that all outcomes have improved in all groups regardless of the exercise delivery method. Considering the supervised programs are not available for everybody, technological options are crucial to implement to help individuals self-manage most aspects of their diabetes.
引用
收藏
页码:49 / 56
页数:8
相关论文
共 50 条
  • [41] A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors
    Haggerty, Ashley F.
    Hagemann, Andrea
    Barnett, Matthew
    Thornquist, Mark
    Neuhouser, Marian L.
    Horowitz, Neil
    Colditz, Graham A.
    Sarwer, David B.
    Ko, Emily M.
    Allison, Kelly C.
    OBESITY, 2017, 25 : S102 - S108
  • [42] Technology-Based Interventions to Promote Diabetes Self-Management Behaviors for Persons Newly Diagnosed with Type 2 Diabetes: A Scoping Review
    Owolabi, Eyitayo O.
    Boakye, Michelle D. S.
    Omololu, Shammah O.
    Smalls, Brittany L.
    Shaibi, Gabriel Q.
    CURRENT DIABETES REPORTS, 2024, : 257 - 272
  • [43] Methods and baseline characteristics for a social engagement technology-based randomized controlled trial for older adults
    Lydon, Elizabeth A.
    Mois, George
    Shende, Shraddha A.
    Myers, Dillon
    Danilovich, Margaret K.
    Rogers, Wendy A.
    Mudar, Raksha A.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 39
  • [44] Participation of Racial and Ethnic Minorities in Technology-Based Interventions to Self-Manage Type 2 Diabetes: A Scoping Review
    Jang, Myoungock
    Johnson, Constance M.
    D'Eramo-Melkus, Gail
    Vorderstrasse, Allison A.
    JOURNAL OF TRANSCULTURAL NURSING, 2018, 29 (03) : 292 - 307
  • [45] A randomized controlled trial of resistance exercise in individuals with ALS - Reply
    Dal Bello-Haas, V. P. M.
    Florence, J. M.
    Kloos, A. D.
    Scheirbecker, J.
    Lopate, G.
    Hayes, S. M.
    Pioro, E. P.
    Mitsumoto, H.
    NEUROLOGY, 2008, 71 (11) : 865 - 866
  • [46] A Randomized, Controlled Trial of Exercise for Parkinsonian Individuals With Freezing of Gait
    Silva-Batista, Carla
    de Lima-Pardini, Andrea Cristina
    Nucci, Mariana Penteado
    Coelho, Daniel Boari
    Batista, Alana
    Pimentel Piemonte, Maria Elisa
    Barbosa, Egberto Reis
    Teixeira, Luis Augusto
    Corcos, Daniel M.
    Amaro Jr, Edson
    Horak, Fay B.
    Ugrinowitsch, Carlos
    MOVEMENT DISORDERS, 2020, 35 (09) : 1607 - 1617
  • [47] Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial
    Rahimi Sakak, Fatemeh
    Moslehi, Nazanin
    Niroomand, Mahtab
    Mirmiran, Parvin
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (05) : 2495 - 2506
  • [48] Diet and exercise interventions for individuals at risk for type 2 diabetes: a scoping review protocol
    MacPherson, Megan
    Cranston, Kaela
    Locke, Sean
    Vis-Dunbar, Mathew
    Jung, Mary E.
    BMJ OPEN, 2020, 10 (11):
  • [49] Glycemic control improvement in individuals with type 2 diabetes with vitamin K2 supplementation: a randomized controlled trial
    Fatemeh Rahimi Sakak
    Nazanin Moslehi
    Mahtab Niroomand
    Parvin Mirmiran
    European Journal of Nutrition, 2021, 60 : 2495 - 2506
  • [50] Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial
    Fatemeh Rahimi Sakak
    Nazanin Moslehi
    Hengameh Abdi
    Parvin Mirmiran
    BMC Complementary Medicine and Therapies, 21